PARLIAMENTARY WRITTEN QUESTION
(20 November 2024)

The Department is aware of the burden of undiagnosed liver disease in the population, and its impact on health and the working years of life lost.

Community Liver Health Checks are being piloted in 19 areas to identify patients with cirrhosis or advanced fibrosis, who are at high risk of hepatocellular carcinomas (HCC). These patients will be referred into, and supported to engage with, National Institute for Care and Excellence recommended six-monthly liver cancer surveillance. Many of the patients identified by this route will also receive lifestyle advice and support which aims to reduce future cancer incidence. From June 2022 to October 2024, over 80,000 fibroscans have been delivered and over 5,600 people have been referred for cancer surveillance.

The Community Liver Health Checks programme is also funding a primary care case finding pilot, which uses primary care records to identify patients at high risk of cirrhosis, and offers them blood tests and fibroscans. The pilots are due to finish in December 2024. To date, over 12,400 people have been tested, and 288 people have been identified to have advanced liver disease requiring cancer surveillance.

More widely, NHS England is also focussed on developing pathways for the early diagnosis of fatty liver disease, and prevention via the work to reduce hepatitis C and B infections and to reduce obesity rates. In addition, the NHS Cancer Programme is working to detect more HCCs, the most common liver cancer, at an early stage, when the chances of survival are higher.